India's SRF looking to enter intermediates business
the pharmaceutical chemicals business, according to national press
reports.
The company has already invested R230 million in two manufacturing facilities at its chemicals complex in Rajasthan as well as an R&D centre focusing on high value-added fluorochemicals, commissioned in 2003-2004.
The two manufacturing facilities are currently undergoing trial runs. One of these will be dedicated to manufacture trifluoroacetic acid, while the second will be a multi-purpose plant to produce a wide range of pharmaceutical chemicals and intermediates.
SRF plans to set up another R&D centre in Chennai to focus on process development on advanced intermediates. The company proposes to recruit about 50 scientists during 2004-2005.
SRF also plans to take advantage of its R&D capabilities to get custom synthesis and contract manufacturing for US and EU-based pharma firms, according to a Business Line report.
